Area of research
Physiology · Immunology and Allergy
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Respiratory and Cough-Related Research, and Sinusitis and nasal conditions.
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics
Dupilumab Improves Lung Function in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation: A Pooled Analysis from the Phase 3 NOTUS and BOREAS Trials
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
The contribution of digital health to net zero patient care in allergic diseases: From concept to practice
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensus
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study
Digital Health Europe (DHE) Twinning on severe asthma—kick-off meeting report
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
Face masks, respiratory patients and COVID-19
Beliefs and preferences regarding biological treatments for severe asthma